SCHEMBL10568392

SCHEMBL10568392

CCOC(=O)c1cn(C(C)c2c(F)cccc2F)cn1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 3/20 0.44
NOTUM Q6P988 1/20 0.43
GAA P10253 1/20 0.41
SMN1; SMN2 Q16637 2/20 0.39
NPC1 O15118 1/20 0.39
RAB9A P51151 1/20 0.39
TP53 P04637 2/20 0.39
GABRB2 P47870 5/20 0.39
GABRA2 P47869 4/20 0.39
GABRA1 P14867 3/20 0.39
CYP3A4 P08684 2/20 0.39
CYP11B1 P15538 2/20 0.39
CYP11B2 P19099 2/20 0.39
LMNA P02545 2/20 0.39
CYP2C9 P11712 1/20 0.39
CYP2C19 P33261 1/20 0.39
ABCB11 O95342 1/20 0.39
ALDH1A1 P00352 2/20 0.38
KDM4E B2RXH2 1/20 0.38
HPGD P15428 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20971369 0.81 GABRB2 (0.55) CYP1A2NOTUMGAANPC1RAB9A
SCHEMBL18316510 0.81 GABRB2 (0.55) CYP1A2NOTUMGAANPC1RAB9A
SCHEMBL29215821 0.81 GABRB2 (0.55) CYP1A2NOTUMGAANPC1RAB9A
SCHEMBL9714322 0.81 ADA (0.48)
SCHEMBL12458255 0.79 NOTUM (0.49) CYP1A2NOTUMGAAGABRB2GABRA2
SCHEMBL28934812 0.78 GAA (0.47) CYP1A2NOTUMGAASMN1; SMN2NPC1
SCHEMBL28934814 0.78 GAA (0.47) CYP1A2NOTUMGAASMN1; SMN2NPC1
SCHEMBL10669079 0.78 ALDH1A1 (0.48) CYP1A2GAASMN1; SMN2TP53GABRB2
SCHEMBL28934718 0.78 GABRA1 (0.45) CYP1A2NOTUMGAAGABRB2GABRA2
SCHEMBL28934720 0.78 GABRA1 (0.45) CYP1A2NOTUMGAAGABRB2GABRA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4851424-A 1-Phenyl-lower alkyl-imidazole 4- or 5-carboxamide compounds which are useful in the treatment of epilepsy CIBA-GEIGY CORPORATION (US) 1989-07-25 US disclosed